Long-acting 2-adrenoceptor agonists: increased risk of death?

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Effect of short- and long-acting 2 -adrenoceptor agonists on pulmonary 2 -adrenoceptor expression in human lung

By Nishikawa M.   Mak J.C.W.   Barnes P.J.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Long-Acting 2-Adrenoceptor Agonists and Exercise-Induced Asthma: Lessons to Guide Us in the Future

By Anderson Sandra D.   Brannan John D.  

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 161-175

Adis International

Access to resources Recommend Favorite

Exosites: their current status, and their relevance to the duration of action of long-acting 2 -adrenoceptor agonists

By Coleman R.A.   Johnson M.   Nials A.T.   Vardey C.J.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 324-330

Elsevier

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite